title: Rational design of allosteric-inhibition sites in classical protein tyrosine phosphatases.
abstract: Protein tyrosine phosphatases (PTPs), which catalyze the dephosphorylation of phosphotyrosine in protein substrates, are critical regulators of metazoan cell signaling and have emerged as potential drug targets for a range of human diseases. Strategies for chemically targeting the function of individual PTPs selectively could serve to elucidate the signaling roles of these enzymes and would potentially expedite validation of the therapeutic promise of PTP inhibitors. Here we report a novel strategy for the design of non-natural allosteric-inhibition sites in PTPs; these sites, which can be introduced into target PTPs through protein engineering, serve to sensitize target PTPs to potent and selective inhibition by a biarsenical small molecule. Building on the recent discovery of a naturally occurring cryptic allosteric site in wild-type Src-homology-2 domain containing PTP (Shp2) that can be targeted by biarsenical compounds, we hypothesized that Shp2's unusual sensitivity to biarsenicals could be strengthened through rational design and that the Shp2-specific site could serve as a blueprint for the introduction of non-natural inhibitor sensitivity in other PTPs. Indeed, we show here that the strategic introduction of a cysteine residue at a position removed from the Shp2 active site can serve to increase the potency and selectivity of the interaction between Shp2's allosteric site and the biarsenical inhibitor. Moreover, we find that 'Shp2-like' allosteric sites can be installed de novo in PTP enzymes that do not possess naturally occurring sensitivity to biarsenical compounds. Using primary-sequence alignments to guide our enzyme engineering, we have successfully introduced allosteric-inhibition sites in four classical PTPs-PTP1B, PTPH-1, FAP-1, and HePTP-from four different PTP subfamilies, suggesting that our sensitization approach can likely be applied widely across the classical PTP family to generate biarsenical-responsive PTPs.
authors.affiliation: Amherst College, Department of Chemistry, Amherst, MA 01002, United States.
authors.forename: Cynthia M
authors.initials: CM
authors.lastname: Chio
authors.affiliation: Amherst College, Department of Chemistry, Amherst, MA 01002, United States.
authors.forename: Xiaoling
authors.initials: X
authors.lastname: Yu
authors.affiliation: Amherst College, Department of Chemistry, Amherst, MA 01002, United States. Electronic address: acbishop@amherst.edu.
authors.forename: Anthony C
authors.initials: AC
authors.lastname: Bishop
mesh_terms: D000495:Allosteric Site / Q000187:drug effects; D000595:Amino Acid Sequence; D001152:Arsenicals / Q000737:chemistry* / Q000494:pharmacology*; D006801:Humans; D008958:Models, Molecular; D008969:Molecular Sequence Data; D017354:Point Mutation; D015202:Protein Engineering; D054592:Protein Tyrosine Phosphatase, Non-Receptor Type 11 / Q000037:antagonists & inhibitors* / Q000737:chemistry / Q000235:genetics* / Q000378:metabolism; D016415:Sequence Alignment
chemical_list: D001152:Arsenicals; D054592:Protein Tyrosine Phosphatase, Non-Receptor Type 11
keywords: Allostery; Biarsenicals; FlAsH; Inhibitor sensitization; Protein engineering; Protein tyrosine phosphatases
references.citation: Drug Discov Today. 2007 May;12(9-10):373-81
references.pmid: 17467573
references.citation: Biochemistry. 2008 Apr 15;47(15):4491-500
references.pmid: 18358001
references.citation: Nat Chem Biol. 2014 Jul;10(7):558-66
references.pmid: 24845231
references.citation: J Am Chem Soc. 2005 Mar 9;127(9):2824-5
references.pmid: 15740097
references.citation: Curr Med Chem. 2009;16(17):2095-176
references.pmid: 19519384
references.citation: Mol Cell Biol. 2001 Nov;21(21):7117-36
references.pmid: 11585896
references.citation: Biochemistry. 2007 Apr 10;46(14):4370-8
references.pmid: 17352459
references.citation: Nat Chem Biol. 2007 Dec;3(12):779-84
references.pmid: 17982447
references.citation: Biochemistry. 2005 May 31;44(21):7704-12
references.pmid: 15909985
references.citation: Proc Natl Acad Sci U S A. 1994 Mar 1;91(5):1624-7
references.pmid: 8127855
references.citation: J Am Chem Soc. 2001 Nov 28;123(47):11608-13
references.pmid: 11716715
references.citation: Curr Opin Cell Biol. 2001 Apr;13(2):182-95
references.pmid: 11248552
references.citation: Bioconjug Chem. 2012 Feb 15;23(2):272-8
references.pmid: 22263876
references.citation: Bioorg Med Chem. 2006 Jan 15;14(2):464-71
references.pmid: 16182535
references.citation: Science. 1998 Jul 10;281(5374):269-72
references.pmid: 9657724
references.citation: Annu Rev Biophys Biomol Struct. 2000;29:577-606
references.pmid: 10940260
references.citation: Nat Struct Mol Biol. 2004 Aug;11(8):730-7
references.pmid: 15258570
references.citation: Biochemistry. 2009 Feb 17;48(6):1399-409
references.pmid: 19166311
references.citation: Bioorg Med Chem. 2005 Apr 15;13(8):2825-36
references.pmid: 15781393
references.citation: J Biol Chem. 1998 Oct 23;273(43):28199-207
references.pmid: 9774441
references.citation: Biochem J. 2007 Feb 15;402(1):1-15
references.pmid: 17238862
references.citation: Anticancer Agents Med Chem. 2012 Jan;12(1):4-18
references.pmid: 21707506
references.citation: J Comput Chem. 2004 Oct;25(13):1605-12
references.pmid: 15264254
references.citation: Science. 2014 Oct 31;346(6209):638-641
references.pmid: 25323695
references.citation: Methods. 2007 Jul;42(3):278-88
references.pmid: 17532515
references.citation: Protein Sci. 2006 Jun;15(6):1500-5
references.pmid: 16672235
references.citation: J Am Chem Soc. 2002 May 29;124(21):6063-76
references.pmid: 12022841
references.citation: Biochem Biophys Res Commun. 2007 May 18;356(4):1011-6
references.pmid: 17408595
references.citation: Drug Discov Today. 2002 Aug 15;7(16):872-9
references.pmid: 12546954
references.citation: J Biol Chem. 2005 Mar 4;280(9):8180-7
references.pmid: 15611135
references.citation: Trends Cell Biol. 2001 Apr;11(4):167-72
references.pmid: 11306297
references.citation: Cell. 2009 Jan 23;136(2):352-63
references.pmid: 19167335
references.citation: Bioorg Med Chem. 2008 Sep 1;16(17):8090-7
references.pmid: 18678493
references.citation: Nature. 2000 Sep 21;407(6802):395-401
references.pmid: 11014197
references.citation: Bioorg Med Chem. 2010 Jul 15;18(14):4884-91
references.pmid: 20594861
references.citation: Bioorg Med Chem Lett. 2006 Aug 1;16(15):4002-6
references.pmid: 16716588
references.citation: Chem Biol. 2008 Oct 20;15(10):1104-15
references.pmid: 18940670
references.citation: Cell. 1998 Feb 20;92(4):441-50
references.pmid: 9491886
references.citation: Biochim Biophys Acta. 2013 Oct;1832(10):1673-96
references.pmid: 23707412
references.citation: Nat Protoc. 2008;3(9):1527-34
references.pmid: 18772880
references.citation: Acta Crystallogr D Biol Crystallogr. 2004 Sep;60(Pt 9):1527-34
references.pmid: 15333922
references.citation: J Am Chem Soc. 2007 Apr 4;129(13):3812-3
references.pmid: 17346049